Thryv prices $80M stock offering at $14/share to fund Keap acquisition

Thryv Holdings, Inc.

Priced 5,715,000 shares at $14.00 each; gross proceeds ~$80M; underwriter has 30-day option for 857,250 additional shares.
Net proceeds ~$76M after underwriting discounts and offering expenses.
Proceeds will fund a portion of the purchase price for the previously announced acquisition of Infusion Software (Keap).
RBC Capital Markets is sole book-runner; offering closed on October 31, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.